Neuritek Therapeutics Inc

CIK: 2036176NYIncorporated: 2019-01-28

Current Offering

$15,000
Target Amount
$1,235,000
Maximum Amount
2024-12-03
Deadline

Security Details

Type: Common Stock
Price per share: $1.50
Shares offered: 10,000+

Offering Costs

Cash commission: 13%
7 - 13 percent
Equity compensation: 3%
Three percent (3%) of securities of the total amount of investments raised in the offering, along the same terms as investors.

Financial Reports

Offering via StartEngine

Offering History

As of 2024-09-04
Raising $15,000 -$1,235,000 via 10,000+ shares of common Stock at $1.50 per share
Deadline: 2024-12-03
Filing date2024-09-04
Current employees2
Act received most recent fiscal year$0.00
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$0.00
Cash equi prior fiscal year$0.00
Cost goods sold most recent fiscal year$0.00
Cost goods sold prior fiscal year$0.00
Long term debt most recent fiscal year$0.00
Long term debt prior fiscal year$0.00
Net income most recent fiscal year$100,981
Net income prior fiscal year$0.00
Revenue most recent fiscal year$0.00
Revenue prior fiscal year$0.00
Short term debt most recent fiscal year$1,500
Short term debt prior fiscal year$0.00
Tax paid most recent fiscal year$0.00
Tax paid prior fiscal year$0.00
Total asset most recent fiscal year$0.00
Total asset prior fiscal year$0.00

Company Information

Corporation
NY
2019-01-28

Latest Metrics

Employees2
Total Assets$0.00
Cash on Hand$0.00
Revenues$0.00
Net Income$100,981

Crowdfunding Portals

This company is raising funds through this portal